Arrhythmias occurring during pregnancy can cause significant symptoms and even death in mother and fetus. The management of these arrhythmias is complicated by the need to avoid harm to the fetus and neonate. It is useful to classify patients with arrhythmias into those with and without structural heart disease. Those with a primary electrical problem, but an otherwise normal heart, often tolerate rapid heart rates without compromise whereas patients with problems such as rheumatic heart disease, congenital heart disease or cardiomyopathy may quickly decompensate during an arrhythmia.
CarruthJE, MivisSB, BroganDR, WengerNK. The electrocardiogram in normal pregnancy. Am Heart J1981;102(Part 1):1075–8
3.
RosanoGM, LeonardoF, SarrelPM, BealeCM, De LucaF, CollinsP. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet1996;347:786–8
4.
GreenwoodJP, ScottEM, StokerJB, WalkerJJ, MaryDA. Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans. Circulation2001;104:2200–4
5.
SchwartzDB, SchamrothL. The effect of pregnancy on the frontal plane QRS axis. J Electrocardiol1979;12:279–81
6.
WengerNK, HurstJW, StrozierVN. Electrocardiographic changes in pregnancy. Am J Cardiol1964;13:774–8
7.
ShotanA, OstrzegaE, MehraA, JohnsonJV, ElkayamU. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol1997;79:1061–4
8.
LiJM, NguyenC, JoglarJA, HamdanMH, PageRL. Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service. Clin Cardiol2008;31:538–41
9.
RomemA, RomemY, KatzM, BattlerA. Incidence and characteristics of maternal cardiac arrhythmias during labor. Am J Cardiol2004;93:931–3
10.
BerlinerblauR, YessianA, LichsteinE, HabermanS, OruciE, JewelewiczR. Maternal arrhythmias of normal labor and delivery. Gynecol Obstet Invest2001;52:128–31
11.
SullivanE, HallB, KingJ. Maternal Deaths in Australia 2003–2005. Maternal Deaths Series. Vol. 3. Australian Institute of Health and Welfare, 2008
12.
TawamM, LevineJ, MendelsonM, GoldbergerJ, DyerA, KadishA. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol1993;72:838–40
13.
LeeSH, ChenSA, WuTJ, Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol1995;76:675–8
14.
KounisNG, ZavrasGM, PapadakiPJ, SoufrasGD, KitrouMP, PoulosEA. Pregnancy-induced increase of supraventricular arrhythmias in Wolff–Parkinson–White syndrome. Clin Cardiol1995;18:137–40
15.
WiderhornJ, WiderhornAL, RahimtoolaSH, ElkayamU. WPW syndrome during pregnancy: increased incidence of supraventricular arrhythmias. Am Heart J1992;123:796–8
HubbardWN, JenkinsBA, WardDE. Persistent atrial tachycardia in pregnancy. Br Med J (Clin Res Ed). 1983;287:327
18.
SzekelyP, SnaithL. Atrial fibrillation and pregnancy. Br Med J.1961;1:1407–10
19.
FusterV, RydenLE, CannomDS, ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm association and the heart rhythm society. Circulation2006;114:e257–354
20.
BrodskyM, DoriaR, AllenB, SatoD, ThomasG, SadaM. New-onset ventricular tachycardia during pregnancy. Am Heart J1992;123(Part 1):933–41
21.
LemeryR, BrugadaP, BellaPD, DugernierT, van den DoolA, WellensHJ. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. Circulation1989;79:990–9
22.
TrappeHJ, BrugadaP, TalajicM, Prognosis of patients with ventricular tachycardia and ventricular fibrillation: role of the underlying etiology. J Am Coll Cardiol1988;12:166–74
23.
HoDS, ZecchinRP, RichardsDA, UtherJB, RossDL. Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia. Lancet1994;344:18–23
24.
KhositsethA, TesterDJ, WillML, BellCM, AckermanMJ. Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome. Heart Rhythm2004;1:60–4
25.
RashbaEJ, ZarebaW, MossAJ, Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation1998;97:451–6
26.
SethR, MossAJ, McNittS, Long QT syndrome and pregnancy. J Am Coll Cardiol2007;49:1092–8
27.
HeradienMJ, GoosenA, CrottiL, Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation?J Am Coll Cardiol2006;48:1410–5
28.
ArnestadM, CrottiL, RognumTO, Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation2007;115:361–7
29.
CopelandGD, SternTN. Wenckebach periods in pregnancy and puerperium. Am Heart J1958;56:291–8
HidakaN, ChibaY, KuritaT, SatohS, NakanoH. Is intrapartum temporary pacing required for women with complete atrioventricular block? An analysis of seven cases. BJOG2006;113:605–7
32.
AntonelliD, BlochL, RosenfeldT. Implantation of permanent dual chamber pacemaker in a pregnant woman by transesophageal echocardiographic guidance. Pacing Clin Electrophysiol1999;22:534–5
33.
GudalM, KervanciogluC, OralD, GurelT, ErolC, SonelA. Permanent pacemaker implantation in a pregnant woman with the guidance of ECG and two-dimensional echocardiography. Pacing Clin Electrophysiol1987;10(Part 1):543–5
34.
ShenCL, HoYY, HungYC, ChenPL. Arrhythmias during spinal anesthesia for Cesarean section. Can J Anaesth2000;47:393–7
35.
DunnJSJr, BrostBC. Fetal bradycardia after IV adenosine for maternal PSVT. Am J Emerg Med2000;18:234–5
36.
ShermanJL, LockeRV. Transplacental neonatal digitalis intoxication. Am J Cardiol1960;6:834–7
37.
RogersMC, WillersonJT, GoldblattA, SmithTW. Serum digoxin concentrations in the human fetus, neonate and infant. N Engl J Med1972;287:1010–3
38.
LuxfordAM, KellawayGS. Pharmacokinetics of digoxin in pregnancy. Eur J Clin Pharmacol1983;25:117–21
39.
GonzalezAR, PhelpsSJ, CochranEB, SibaiBM. Digoxin-like immunoreactive substance in pregnancy. Am J Obstet Gynecol1987;157:660–4
40.
LoughnanPM. Digoxin excretion in human breast milk. J Pediatr1978;92:1019–20
41.
TadmorOP, KerenA, RosenakD, The effect of disopyramide on uterine contractions during pregnancy. Am J Obstet Gynecol1990;162:482–6
42.
FujinagaM. Assessment of teratogenic effects of lidocaine in rat embryos cultured in vitro. Anesthesiology1998;89:1553–8
43.
KuhnertBR, KnappDR, KuhnertPM, ProchaskaAL. Maternal, fetal, and neonatal metabolism of lidocaine. Clin Pharmacol Ther1979;26:213–20
44.
KimWY, PomeranceJJ, MillerAA. Lidocaine intoxication in a newborn following local anesthesia for episiotomy. Pediatrics. 1979;64:643–5
45.
BrownWUJr, BellGC, AlperMH. Acidosis, local anesthetics, and the newborn. Obstet Gynecol.1976;48:27–30
46.
LewisAM, PatelL, JohnstonA, TurnerP. Mexiletine in human blood and breast milk. Postgrad Med J1981;57:546–7
47.
TimmisAD, JacksonG, HoltDW. Mexiletine for control of ventricular dysrhythmias in pregnancy. Lancet1980;2(Part 1):647–8
48.
HallCM, Ward PlattMP. Neonatal flecainide toxicity following supraventricular tachycardia treatment. Ann Pharmacother2003;37:1343–4
49.
MageeLA, ElranE, BullSB, LoganA, KorenG. Risks and benefits of beta-receptor blockers for pregnancy hypertension: overview of the randomized trials. Eur J Obstet Gynecol Reprod Biol2000;88:15–26
50.
BaylissH, ChurchillD, BeeversM, BeeversDG. Anti-hypertensive drugs in pregnancy and fetal growth: evidence for ‘pharmacological programming’ in the first trimester?Hypertens Pregnancy2002;21:161–74
51.
OudijkMA, RuskampJM, VerversFF, Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol2003;42:765–70
52.
BabinJP, CarreM, MartinC. Possible embryofetopathy caused by beta-blocker (sotalol) taken throughout the pregnancy. Pediatrie1985;40:129–36
53.
SkoldAC, DanielssonBR. Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol. Pharmacol Toxicol2001;88:34–9
54.
HackettLP, Wojnar-HortonRE, DusciLJ, IlettKF, RobertsMJ. Excretion of sotalol in breast milk. Br J Clin Pharmacol1990;29:277–8
55.
PlompTA, VulsmaT, de VijlderJJ. Use of amiodarone during pregnancy. Eur J Obstet Gynecol Reprod Biol1992;43:201–7
56.
MageeLA, DownarE, SermerM, BoultonBC, AllenLC, KorenG. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol1995;172(Part 1):1307–11
57.
MageeLA, NulmanI, RovetJF, KorenG. Neurodevelopment after in utero amiodarone exposure. Neurotoxicol Teratol1999;21:261–5
58.
OvadiaM, BritoM, HoyerGL, MarcusFI. Human experience with amiodarone in the embryonic period. Am J Cardiol1994;73:316–7
59.
McKennaWJ, HarrisL, RowlandE, WhitelawA, StoreyG, HoltD. Amiodarone therapy during pregnancy. Am J Cardiol.1983;51:1231–3
60.
ScottWJJr, ResnickE, HummlerH, ClozelJP, BurginH. Cardiovascular alterations in rat fetuses exposed to calcium channel blockers. Reprod Toxicol1997;11:207–14
61.
Weber-SchoendorferC, HannemannD, MeisterR, The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol2008;26:24–30
62.
NataleA, DavidsonT, GeigerMJ, NewbyK. Implantable cardioverter-defibrillators and pregnancy: a safe combination?. Circulation1997;96:2808–12
63.
BarnesEJ, EbenF, PattersonD. Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section. BJOG2002;109:1406–7
64.
DamilakisJ, TheocharopoulosN, PerisinakisK, Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation2001;104:893–7
65.
LindsayBD, EichlingJO, AmbosHD, CainME. Radiation exposure to patients and medical personnel during radiofrequency catheter ablation for supraventricular tachycardia. Am J Cardiol1992;70:218–23
66.
BombelliF, LagonaF, SalvatiA, CatalfamoL, FerrariAG, PapponeC. Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy. Obstet Gynecol2003;102(Part 2):1171–3
67.
GoodwinAP, PearceAJ. The human wedge. A manoeuvre to relieve aortocaval compression during resuscitation in late pregnancy. Anaesthesia1992;47:433–4
68.
2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 10.8: Cardiac arrest associated with pregnancy. Circulation2005;112(Suppl. 1):IV150–3
